🚀 Kicking off our T cell isolation & culture efforts from #pancreatic tumors! Big thanks to @STEMCELLTech for a great demo — invaluable workflow tips + expert know-how to optimize our process. Excited to push this forward! 🔬💥 #ImmunoOncology #Tcells #PancreaticCancer

At #BioNTech, we’re looking forward to #ASCO25, presenting oncology pipeline progress: mRNA cancer immunotherapies, ADCs, and next-gen immunomodulators and targeted therapies. 🗓 May 30 – June 3 | Chicago .📍 Booth #35165. #CancerResearch #ImmunoOncology #OncologyInnovation

📢 Now hiring! The Dept. of #BiologicalChemistry & #Pharmacology & #PIIO at @OhioState invite applications for a #tenure_track_faculty in #structural_biology & #ImmunoOncology. Focus: #molecular_mechanisms of #immune_regulation in #cancer. 🔬🧬. 🔗

Thank you to @myESMO, @ben_schlechter and @DanaFarber for presenting new results of #BOT/BAL in refractory MSS #colorectalcancer. #CancerResearch #ImmunoOncology #ESMOGI2025

#ColorectalCancer is on track to become the leading cause of cancer deaths in adults under 50 by 2030. Agenus CDO Dr. Richard Goldberg outlines key clinical trends and therapeutic responses to this rising public health concern. #ColorectalCancer #Oncology #ImmunoOncology

Μιλώντας για την άνοσο ογκολογική πρακτική και τα τεράστια άλματα που έγιναν τα τελευταία χρόνια με την χρήση των άνοσοθεραπειών στην θεραπεία του καρκίνου . #Immunotherapy .#immunooncology.#GeorgeAstras.#FightingCancerTogether

🧬 How to evaluate the cytotoxicity of your CAR-T cells?. Most tools rely on endpoints or destructive prep. With Nanolive’s LIVE T Cell Assay, you can monitor T cell behavior live, no dyes, no labels. 🎥 Watch here: #ImmunoOncology

Agenus & @ZydusUniverse announce a $141M partnership to advance BOT/BAL, combining IO innovation with global manufacturing to expand cancer immunotherapy access in India & beyond. Read more: #ImmunoOncology #GlobalHealth #Manufacturing #CancerResearch

Agenus announced #CancerResearch collaboration w/ @NOETIK_ai – the partnership leverages AI-powered virtual cell models to advance precision #immunotherapy and identify people that may benefit most to #BOT/BAL treatment. Read more: #ImmunoOncology

T cells growing strong! 💪 First look at spleen-derived T cell cultures from our pancreatic tumor models. Excited to use these for #TCRseq & functional studies @STEMCELLTech @WeillCornell .#ImmunoOncology #PancreaticCancer #RASmutant #Tcell #CancerResearch

Implementing #ImmunoOncology in #GynecologicCancer care for #Veterans: Elevate your practice with expert insights on the latest data! 8/22 at 2:00 PM EDT. Produced with @navref. #PeerView #Oncology

Thank you, Dr. @MengzeLv Lyu, for an outstanding seminar today! Excited to see where your research on #host_microbiota interactions and their impact on #cancer and #inflammation leads next! #ImmunoOncology #Microbiome #PIIO

Imugene reports two additional complete responses in azer-cel CAR T Phase 1b trial | $IMU Media coverage by @AusBiotech . #AzerCel #Biotech #ImmunoOncology #CAR_T #CancerResearch #DLBCL #CellTherapy #Oncology #BloodCancer #CancerTreatment

We are under way at @HiltonLeedsCity diving into Capacity Management in Immuno-Oncology Service Delivery. Another fantastic turn-out — great to see so many colleagues passionate about improving cancer services! 💬🧬 #ImmunoOncology #CancerCare #Oncology #HealthInnovation

The 6th edition of the MENA Immuno-Oncology Forum (MIOF VI) opened with a distinguished ceremony led by key figures from medicine, academia, and national leadership. 🤝💡🧬. #MIOF2025 #ImmunoOncology #CancerCare #AUBFM #AUBMedicine #HPDC

We’re looking forward to the next #Immunology, #Infection, & #ImmunoOncology (i3) Seminar Series on Tuesday, 4/29 at NOON, where Dr. Marco Davila (@RoswellPark) will give a seminar titled “Using pre-clinical models and patient samples to identify how #immune_cells regulate

Percheron inks global deal for HMBD-002 cancer drug PercheronTherapeutics, HMBD002, CancerTreatment, BiotechNews, ImmunoOncology, OncologyResearch, BiotechInvesting, HummingbirdBioscience

The @AACR Immuno-Oncology Research Fellowships Provide $130,000 to Support Clinical Fellows. #ImmunoOncology #ImmuneOnc #Immunotherapy #AACR #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

This week, our CMO, Dr. Thomas Heineman, MD, PhD, will speak as part of Technology Networks’ virtual event on the advances in #immunooncology. Register here to learn how #pelareorep is driving progress in cancers by activating the immune system: